|
Marché Fermé -
Nasdaq
22:00:00 30/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,3030 USD | -1,53% |
|
-19,24% | -61,31% |
| 24/09 | ATyr Pharma, Inc. annonce un accord avec la FDA sur l’étude de phase 3 de l’efzofitimod dans la sarcoïdose pulmonaire | CI |
| 24/09 | Les plus fortes hausses avant l’ouverture | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1,53% | -19,24% | -43,01% | -49,23% | -61,31% | -58,00% | -80,82% | -96,66% | -99,32% | 29,72 M | |
| +4,16% | -0,36% | +8,11% | +34,40% | +84,62% | +49,37% | +94,17% | +9,52% | - | 74,46 Md | |
| -0,40% | +1,01% | -4,85% | +6,25% | +17,63% | +27,49% | +80,56% | +221,22% | +5 473,03% | 60,14 Md | |
| -0,97% | -0,46% | -1,80% | +0,85% | +5,50% | +6,14% | +34,93% | -18,38% | +204,24% | 48,15 Md | |
| -0,05% | +0,37% | +2,93% | +39,14% | +19,27% | +41,54% | +36,65% | +12,24% | +231,67% | 44,25 Md | |
| +0,38% | +7,61% | -0,15% | +9,60% | +157,70% | +339,53% | +641,55% | +646,13% | - | 43,99 Md | |
| +0,18% | +0,26% | +1,77% | +28,41% | +20,45% | +7,41% | +103,45% | +0,81% | +1 087,73% | 41,61 Md | |
| -0,67% | +0,17% | -5,93% | +2,54% | +3,09% | +7,60% | +46,37% | -16,71% | +137,67% | 29,97 Md | |
| +4,77% | +6,16% | +14,76% | +61,99% | +78,28% | +36,77% | +22,78% | -55,69% | - | 29,31 Md | |
| -1,29% | -3,55% | -6,30% | +7,05% | -34,42% | -20,74% | +352,04% | +314,45% | +686,09% | 24,93 Md | |
| -0,27% | -0,16% | -3,26% | +5,64% | +3,26% | -0,32% | -9,52% | -63,99% | - | 24,69 Md | |
| -0,66% | +2,25% | +8,01% | +28,83% | +14,41% | +16,74% | -5,11% | -15,86% | +103,06% | 21,27 Md | |
| +0,33% | +1,14% | +5,08% | +17,86% | +11,13% | +21,40% | +157,79% | +229,77% | +1 990,35% | 17,42 Md | |
| +1,67% | +3,40% | -12,90% | +0,58% | +186,76% | +161,70% | +345,14% | +1 588,11% | +667,01% | 15,8 Md | |
| -0,03% | -3,55% | +4,78% | +9,52% | +20,16% | +18,90% | +43,26% | -29,18% | +82,17% | 14,79 Md | |
| -0,11% | +2,11% | -13,39% | -14,58% | - | - | - | - | - | 14,96 Md | |
| -0,82% | +6,93% | +29,90% | +41,38% | +38,70% | +1,47% | - | - | - | 14,78 Md | |
| -0,41% | +2,96% | +6,90% | +7,35% | +33,26% | +41,43% | +167,32% | +176,30% | +356,68% | 14,47 Md | |
| +2,96% | +0,83% | -2,05% | +11,65% | +24,17% | -5,25% | +535,77% | - | - | 14,83 Md | |
| -0,32% | +6,38% | +2,35% | +30,08% | +47,89% | +88,55% | +50,53% | -28,51% | +253,98% | 14,08 Md | |
| Moyenne | +0,42% | +1,01% | -0,45% | +13,97% | +35,29% | +41,14% | +145,38% | +169,03% | +859,57% | 28,2 Md | |
| Moyenne pondérée par Capi. | +0,74% | +1,78% | +1,61% | +18,96% | +43,19% | +52,54% | +146,20% | +147,73% | +1 363,65% |
- Bourse
- Actions
- Action ATYR
- Secteur aTyr Pharma, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
